Skip to main content

Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes.

Publication ,  Journal Article
Madonna, MC; Fox, DB; Crouch, BT; Lee, J; Zhu, C; Martinez, AF; Alvarez, JV; Ramanujam, N
Published in: Mol Cancer Res
July 2019

With the large number of women diagnosed and treated for breast cancer each year, the importance of studying recurrence has become evident due to most deaths from breast cancer resulting from tumor recurrence following therapy. To mitigate this, cellular and molecular pathways used by residual disease prior to recurrence must be studied. An altered metabolism has long been considered a hallmark of cancer, and several recent studies have gone further to report metabolic dysfunction and alterations as key to understanding the underlying behavior of dormant and recurrent cancer cells. Our group has used two probes, 2-[N-(7-nitrobenz-2-oxa-1, 3-diaxol-4-yl) amino]-2-deoxyglucose (2-NBDG) and tetramethyl rhodamine ethyl ester (TMRE), to image glucose uptake and mitochondrial membrane potential, respectively, to report changes in metabolism between primary tumors, regression, residual disease, and after regrowth in genetically engineered mouse (GEM)-derived mammospheres. Imaging revealed unique metabolic phenotypes across the stages of tumor development. Although primary mammospheres overexpressing Her2 maintained increased glucose uptake ("Warburg effect"), after Her2 downregulation, during regression and residual disease, mammospheres appeared to switch to oxidative phosphorylation. Interestingly, in mammospheres where Her2 overexpression was turned back on to model recurrence, glucose uptake was lowest, indicating a potential change in substrate preference following the reactivation of Her2, reeliciting growth. Our findings highlight the importance of imaging metabolic adaptions to gain insight into the fundamental behaviors of residual and recurrent disease. IMPLICATIONS: This study demonstrates these functional fluorescent probes' ability to report metabolic adaptations during primary tumor growth, regression, residual disease, and regrowth in Her2 breast tumors.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Mol Cancer Res

DOI

EISSN

1557-3125

Publication Date

July 2019

Volume

17

Issue

7

Start / End Page

1545 / 1555

Location

United States

Related Subject Headings

  • Receptor, erbB-2
  • Receptor, ErbB-2
  • Phenotype
  • Organometallic Compounds
  • Oncology & Carcinogenesis
  • Neoplasm Recurrence, Local
  • Membrane Potential, Mitochondrial
  • Mammary Glands, Animal
  • Humans
  • Glucose
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Madonna, M. C., Fox, D. B., Crouch, B. T., Lee, J., Zhu, C., Martinez, A. F., … Ramanujam, N. (2019). Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes. Mol Cancer Res, 17(7), 1545–1555. https://doi.org/10.1158/1541-7786.MCR-18-0618
Madonna, Megan C., Douglas B. Fox, Brian T. Crouch, Jihong Lee, Caigang Zhu, Amy F. Martinez, James V. Alvarez, and Nirmala Ramanujam. “Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes.Mol Cancer Res 17, no. 7 (July 2019): 1545–55. https://doi.org/10.1158/1541-7786.MCR-18-0618.
Madonna MC, Fox DB, Crouch BT, Lee J, Zhu C, Martinez AF, et al. Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes. Mol Cancer Res. 2019 Jul;17(7):1545–55.
Madonna, Megan C., et al. “Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes.Mol Cancer Res, vol. 17, no. 7, July 2019, pp. 1545–55. Pubmed, doi:10.1158/1541-7786.MCR-18-0618.
Madonna MC, Fox DB, Crouch BT, Lee J, Zhu C, Martinez AF, Alvarez JV, Ramanujam N. Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes. Mol Cancer Res. 2019 Jul;17(7):1545–1555.

Published In

Mol Cancer Res

DOI

EISSN

1557-3125

Publication Date

July 2019

Volume

17

Issue

7

Start / End Page

1545 / 1555

Location

United States

Related Subject Headings

  • Receptor, erbB-2
  • Receptor, ErbB-2
  • Phenotype
  • Organometallic Compounds
  • Oncology & Carcinogenesis
  • Neoplasm Recurrence, Local
  • Membrane Potential, Mitochondrial
  • Mammary Glands, Animal
  • Humans
  • Glucose